Correlation Between ALK Abell and PsyBio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ALK Abell and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ALK Abell and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ALK Abell AS and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on ALK Abell and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ALK Abell with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ALK Abell and PsyBio Therapeutics.

Diversification Opportunities for ALK Abell and PsyBio Therapeutics

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between ALK and PsyBio is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding ALK Abell AS and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and ALK Abell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ALK Abell AS are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of ALK Abell i.e., ALK Abell and PsyBio Therapeutics go up and down completely randomly.

Pair Corralation between ALK Abell and PsyBio Therapeutics

Assuming the 90 days horizon ALK Abell is expected to generate 19.57 times less return on investment than PsyBio Therapeutics. But when comparing it to its historical volatility, ALK Abell AS is 15.07 times less risky than PsyBio Therapeutics. It trades about 0.04 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  5.89  in PsyBio Therapeutics Corp on October 15, 2024 and sell it today you would lose (5.88) from holding PsyBio Therapeutics Corp or give up 99.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

ALK Abell AS  vs.  PsyBio Therapeutics Corp

 Performance 
       Timeline  
ALK Abell AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ALK Abell AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
PsyBio Therapeutics Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PsyBio Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

ALK Abell and PsyBio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ALK Abell and PsyBio Therapeutics

The main advantage of trading using opposite ALK Abell and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ALK Abell position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.
The idea behind ALK Abell AS and PsyBio Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stocks Directory
Find actively traded stocks across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments